Medications

US company withdraws ALS drug after it fails in trial

Amylyx Pharmaceuticals announced Thursday it was withdrawing its approved treatment against the deadly neurodegenerative disease ALS after clinical data found no evidence the drug worked.

Medical economics

Woman in 'shock' over $6,000 bill for lifesaving rabies treatment

Follwoing a a suspected bat bite Caroline Ford, worried she may have been exposed to rabies, sought treatment from AdventHealth Altamonte Springs. She called her insurance company, Anthem Blue Cross, and expected she'd need ...

page 1 from 40